GENETIC RISKS MAY LEAD TO STATIN MYOPATHY – (12-09-04)



GENETIC RISK FACTORS FOR STATIN MYOPATHY FOUND; COENZYME Q10, CARNITINE SUPPLEMENTS MIGHT HELP

I will refrain from dancing around saying “I told you so.” I have always noted that I felt the deaths that occurred with Baychol were most likely due to a genetic suseptability to a lower CoQ10 status. The statins are well known to inhibit the production of CoQ10 while it is lowering cholesterol. So, take a person who has a genetically diminished ability to produce CoQ10 and shut that production down. These people literally melted because one of the main protectors against oxidative stress was taken away.

Recent findings have confirmed that this is indeed the pathway that these fatal reactions took. However, what continues to stump me is that researchers would suggest giving CoQ10 and L-carnitine along with the statin drugs. With literally no end to the natural approaches to lowering cholesterol, NONE of which required another natural compound to be used to protect from KILLING the patient, why even think about using statins? This mindset escapes me.

Read entire article here

 

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Cholesterol
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”